Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Cogstate Ltd ( (AU:CGS) ) has issued an announcement.
Cogstate Ltd has provided an updated notification to the ASX regarding its ongoing on-market share buy-back of ordinary fully paid shares under code CGS. The update, dated 25 March 2026, reports that the company has bought back a cumulative 852,506 shares prior to the latest trading day and repurchased a further 124,083 shares on the previous day as part of this program.
The continuing execution of the buy-back indicates Cogstate is actively returning capital to shareholders and reducing its share count, which can enhance earnings per share and potentially support the stock price. This steady pace of daily repurchases underscores management’s confidence in the company’s valuation and may be viewed positively by investors seeking capital management discipline.
The most recent analyst rating on (AU:CGS) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Cogstate Ltd stock, see the AU:CGS Stock Forecast page.
More about Cogstate Ltd
Cogstate Ltd is an Australian-listed company in the cognitive science and technology space, with its ordinary fully paid shares traded on the ASX under the ticker CGS. The company provides digital cognitive assessment and related services, typically focused on clinical trials, healthcare, and research markets that require precise measurement of brain function over time.
Average Trading Volume: 192,290
Technical Sentiment Signal: Buy
Current Market Cap: A$362.5M
For detailed information about CGS stock, go to TipRanks’ Stock Analysis page.